Two patients with acute changes suggesting acute hepatitis after parenteral amiodarone
administration are described. No other explanation for liver damage was found in these …

Following treatment with amiodarone, a patient developed weight loss, fatigue and severe
myopathy, without respiratory symptoms. A solitary lung infiltrate, impaired thyroid and liver …

We describe an interesting case of a woman with decompensated cirrhosis, ischaemic heart
disease and prolonged QT interval, who developed a new-onset atrial fibrillation. During …

DISCUSSION Amiodarone has a variable effect on the liver. Acute hepatitis after parenteral
administration with normal-ization of liver function despite continuation of drug infusion (3) …

DISCUSSION Despite its ubiquitous and clinically important role as a central antiarrhythmic
agent, amiodarone's significant toxicity and side effect profile represent a considerable …

A 72 year old white man developed acute hepatic impairment and renal failure within 24
hours of starting intravenous amiodarone for paroxysmal ventricular tachycardia. After …

We read with interest the letter by Perger et al.[1] where the authors describe the case of a
fatal liver failure in a 83 years old man started on atorvastatin 2 weeks before. In their report …

The cause of fuhninant hepatic failure is unknown in more than half the cases in Japan (1).
We have suggested that many cases of fuhninant hepatic failure or acute hepatitis with no …

Morphological and biochemical investigations were performed in guinea pigs after 1, 3, 5
and 16 weeks of amiodarone feeding. The most prominent morphological finding was an …

We read with interest the study by Solaet al., 1 who found that 39 patients (67%) had a very
alarming decrease in their serum sodium levels! 5 mEq/L during terlipressin treatment for …